Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Dr Reddys unveils generic version of Vitamin K1 injection in US

      Dr Reddys unveils generic version of Vitamin K1 injection in US

      Medical Dialogues Bureau25 Jun 2019 10:52 AM IST
      The Vitamin K1 (Phytonadione) for Injectable Emulsion USP, 10 mg/ml brand and generic, had combined US sales of approximately USD 46.6 million MAT for...
      Lawsuit: Generic drug makers used code to fix price increases

      Lawsuit: Generic drug makers used code to fix price increases

      Medical Dialogues Bureau25 Jun 2019 9:15 AM IST
      The alleged conspiracy targeted more than 100 different generic drug(s), including treatments for diabetes, cancer, arthritis and other medical...
      Oklahoma judge approves Teva Pharma USD 85 million opioid settlement

      Oklahoma judge approves Teva Pharma USD 85 million opioid settlement

      Medical Dialogues Bureau25 Jun 2019 9:00 AM IST
      U.S: An Oklahoma judge on Monday approved a revised $85 million settlement with Teva Pharmaceutical Industries Ltd (Teva Pharma) resolving claims by...
      Novartis, Glenmark enter partnership to commercialize, distribute respiratory drugs Seebri, Onbrize, Ultibro

      Novartis, Glenmark enter partnership to commercialize, distribute respiratory drugs Seebri, Onbrize, Ultibro

      Medical Dialogues Bureau24 Jun 2019 3:02 PM IST
      Under the terms of the agreement, Novartis will remain the holder of the registration of the drugs Seebri, Onbrize and Ultibro and will be responsible...
      Glenmark Pharma Ryaltris gets Complete Response Letter from USFDA

      Glenmark Pharma Ryaltris gets Complete Response Letter from USFDA

      Medical Dialogues Bureau24 Jun 2019 9:30 AM IST
      The CRL cites deficiencies in the Drug Master File pertaining to one of the active pharmaceutical ingredients and in manufacturing facilities,...
      GSK Pharma to optimise product portfolio to drive growth in India

      GSK Pharma to optimise product portfolio to drive growth in India

      Medical Dialogues Bureau24 Jun 2019 9:19 AM IST
      GSK is also looking to launch some new products in the country over the next 15 months as it adopts a more structured approach to engage trade channel...
      No formal warning issued from AIIMS regarding adverse effects of e-cigarettes: Minister informs Parliament

      No formal warning issued from AIIMS regarding adverse effects of e-cigarettes: Minister informs Parliament

      Medical Dialogues Bureau23 Jun 2019 10:15 AM IST
      In response to a question on whether AIIMS has issued any warning regarding harmful effects of e-cigarettes, he said the premier medical institute has...
      Sanofi, Google team up to discover better treatments

      Sanofi, Google team up to discover better treatments

      Medical Dialogues Bureau23 Jun 2019 9:05 AM IST
      Sanofi and Google will use data sets to improve their understanding of key diseases and extract patients' insights and feedback, the companies said in...
      Novartis MS drug Mayzent price out of line with benefit; says US group

      Novartis MS drug Mayzent price out of line with benefit; says US group

      Medical Dialogues Bureau23 Jun 2019 9:00 AM IST
      The Boston-based Institute for Clinical and Economic Review (ICER), which has been reviewing Mayzent for months, recommended that Novartis lower the...
      GSK eyes sale of $1.2 billion consumer health drugs; says report

      GSK eyes sale of $1.2 billion consumer health drugs; says report

      Medical Dialogues Bureau22 Jun 2019 8:59 AM IST
      GSK is streamlining its product offering as it prepares to fold its consumer business into a joint venture with Pfizer in the second half of this...
      Piramal Pharma invests over Rs 69 crore to expand its API capability

      Piramal Pharma invests over Rs 69 crore to expand its API capability

      Medical Dialogues Bureau21 Jun 2019 10:00 AM IST
      The new wing at the Riverview site is dedicated to the production of HPAPIs with low occupational exposure levels (OELs), Piramal Pharma Solutions...
      Merck CEO sees legal challenge if US adopts drug pricing based on other countries

      Merck CEO sees legal challenge if US adopts drug pricing based on other countries

      Medical Dialogues Bureau21 Jun 2019 9:00 AM IST
      Earlier on Thursday, Merck executives touted the company's pipeline of experimental drugs beyond its blockbuster cancer treatment Keytruda.NEW YORK:...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok